Microbiology expert Abby Roth provides guidance to pharmacy for the processes of sampling and reading media. Topics include:
By being mindful of USP <800> standards for CSTD use, facilities can enjoy workflow and compliance improvements. Seth Eisenberg, RN, ASN, OCN, BMTCN, will share the benefits for both pharmacy and nursing when taking a coordinated approach to implementation, including:
Drug diversion threatens patient safety, staff safety and performance, and carries both financial and legal risks. Post-pandemic staffing challenges, including high turnover and reliance on temporary staff, make monitoring medication more difficult. While most hospitals and health systems know diversion occurs, they often struggle to allocate the necessary resources, time, and technology to combat the issue.
Learn how an industry-leading facility implemented a highly effective, automated drug diversion monitoring system despite these challenges. In this webinar, Alex Rodriguez, MHIIM, CPhT, and William Mabry, PharmD, MBA, share their success strategies, including:
Presenting PP&P’s latest survey data, Fred Massoomi and David Aguero examine current automation budgeting trends, new directions in technology acquisition, and the value of adding such systems. Fred and David will explore emerging technologies most widely considered by hospital pharmacy, such as:
Christine Hong, BS, will help connect the dots between microbiology and environmental monitoring for cleanroom compliance, safety, and efficiency. Topics include:
Lou Diorio, principal at LDT Health Solutions, reviews the latest trends in outsourced compounding, including:
Allison Young, PharmD, MS, BSCSP, shares lessons learned from a recent, extensive cleanroom installation. Topics include:
In the continuing effort toward complete USP <800> compliance, Fred Massoomi and Kevin Hansen will explore PP&P’s most recent survey data with a focus on key issues, such as:
Radio frequency identification (RFID) is rapidly becoming an essential tool for medication management within the pharmacy. In this webinar, David Aguero, PharmD, MSTL, FAMIA, FASHP, will address:
Because many questions remain about cleanroom compliance, Patti Kienle will clarify common equipment myths in this webinar, including:
Now that USP <797> is official, how does your pharmacy stack up? Attend this webinar, based on PP&P’s State of Pharmacy Compounding survey data for 2024, as Fred Massoomi and Kevin Hansen examine the following trends:
Mount Sinai Health System onboarded sterile compounding automation to gain workflow efficiencies across multiple sites. This webinar will present an executive’s perspective from Susan Mashni, PharmD, BCPS, on best practices to:
Diversion occurs everywhere.
In this webinar, Brianna Graham, MSN, RN, NPD-BC, diversion prevention specialist at a multi-hospital health system in the midwest, will share expert guidance on adopting a diversion system, focusing on the following:
The Joint Commission is now utilizing USP <797> guidelines as cited under CMS, regardless of how a given state board has implemented USP guidelines. Patti Kienle will address the following in this informative and timely webinar:
Microbiology expert Abby Roth will guide pharmacies in incubator use for USP <797> environmental monitoring samples. Topics include:
Use of emerging technologies such as robotics, CSTDs, RFID, and artificial intelligence are on the rise, according to PP&P’s latest survey data. In this webinar, Fred Massoomi and Ghalib Abbasi will examine where automation and technology are headed as we move toward a new year. Learn how pharmacies across the country are adapting to new developments and innovations.
Indiana University Health established a regional compounding center to provide CSPs to their 18 hospitals, 300 doctor offices, outpatient pharmacies, clinics, and homecare services. Allison L. Young, PharmD, MS, BCSCP, will teach attendees how to move from goal setting to actualization, key elements to seek in a vendor partnership, and design aspects to consider.
In this webinar presented by Patti Kienle, attendees will learn how to ensure quality control in compliance with USP <797>. Patti will share her expert knowledge on the requirements for QA/QC, updates to release testing, and the documentation requirements for SOPs, master formulation records, and compounding records.
Attend this webinar on Friday, October 27, from 1:00-1:20PM ET.
Selecting an outsourced compounding partner requires due diligence in the complex regulatory landscape. In this webinar, Lou Diorio, principal at LDT Health Solutions, reviews the current trends in outsourced compounding and describes the steps to establish a vendor partnership, including:
Learn how to prepare for a state BOP inspection of your cleanroom in this webinar presented by Lindsey Amerine. Lindsey will review commonly overlooked items that can lead to inspection problems, discuss how to reconcile BOP requirements that differ from USP, and outline how to respond to recommendations and citations.
Protecting health care personnel from HD exposure is an essential pharmacy responsibility, and USP <800> establishes guidelines to mitigate this risk. In this webinar, based on PP&P’s most recent survey data, Fred Massoomi and Deanne Halvorsen will review barriers to achieving compliance, recent inspection focal points, and the current state of compliance to USP <800> by hospitals nationwide.
The webinar will review:
Learn how one facility has incorporated two IV compounding robots to bring outsourced production in-house to achieve a financial benefit and to ensure supply chain control. Thomas Moniz, Director of Business and Finance in the department of pharmacy at Brigham & Women’s Hospital, will review the technological advantages, batch compounding considerations, and workflow improvements associated with implementing this automation.
Technician retention continues to be a challenge for pharmacy, and this pressure is exacerbated by the need to ensure USP compliance. Angela Cassano—an expert in sterile compounding, technician integration, and quality assurance—will present recognition strategies to improve technician retention, identify protocols to systemize and standardize training, and outline the connection between effective training and compliance success.
Given drug shortages and staffing challenges, adopting ready-to-use products can reduce compounding risks and simplify distribution. VANCO READY® Vancomycin Injection, USP, is a premix, room temperature stable formulation. VANCO READY® has a boxed warning and is not for use during first and second trimester of pregnancy. Cody Parsons will discuss the operationalization of RTU vancomycin, outlining important patient considerations, storage requirements, EHR adaptation, and workflow simplifications. For full prescribing and safety information please visit www.vancoready.com.
Staying current with USP regulations is an essential pharmacy responsibility. In this webinar, based on PP&P’s State of Pharmacy Compounding survey data for 2023, Fred Massoomi and Deanne Halvorsen will discuss recent compounding inspection focal points, review the current state of compliance to USP <797> by hospitals nationwide, and summarize the changing regulatory requirements.
The new USP <797> guidelines include an increased frequency for environmental monitoring sampling. Microbiology expert Abby Roth will help pharmacies build a sampling program now that facilities are taking a lead role in ensuring EM compliance, rather than relying on their certifiers to do so.
Jason Koury and Andy Teel of University of New Mexico Hospitals will describe utilizing an IV workflow management system to standardize the preparation of hazardous and non-hazardous extemporaneous oral compounds. They will share their facility’s experience with establishing the system, including tips to help improve patient safety.
The 2021 proposed changes to USP <797> offer additional details about pharmacy technician training. A standardized training program can improve consistency and help achieve compliance. In this webinar, Angela Cassano will review the creation of SOPs, establishing training documentation, and the connection between effective training and technician retention.
Given the complex regulatory landscape, selecting an outsourced compounding partner requires due diligence. In this webinar, Lou Diorio, principal at LDT Health Solutions, reviews the current regulatory landscape and outlines the steps necessary to select the right vendor, including:
With the adoption of an automated IV workflow management system in our cleanroom, we have realized significant safety improvements and optimized PN operations. Learn how this automation can be leveraged to avoid common roadblocks and deliver measurable improvements:
With the 2021 proposed changes to USP <797>, the frequency of environmental monitoring will increase. Those facilities that have relied on their certifiers to conduct EM will now need to develop in-house expertise. In this webinar, microbiology expert Abby Roth will discuss how to approach this process, including establishing P&Ps, incubation needs, and other considerations.
As drug and staffing shortages continue to affect hospital pharmacy, solutions can be realized in implementing a clinical decision support (CDS) system that provides reliable, easily accessible inventory data. In this webinar, David Aguero, director of medication systems and informatics at St. Jude’s Children’s Research Hospital, will illustrate the improved data management that can be achieved by working with a CDS system, thereby helping pharmacy to meet the challenge of shortages.
Protecting health care personnel from HD exposure is an essential pharmacy responsibility, and USP <800> establishes guidelines to mitigate this risk. In this webinar, based on PP&P’s most recent survey data, Fred Massoomi and Deanne Halvorsen will review regulatory requirements, recent inspection focal points, and the current state of compliance to USP <800> by hospitals nationwide.
The webinar will review:
Connecting the safety of PN ordering with an IV workflow management system delivers improvements in compounding safety by removing the human element from the process. Formulas are verified prior to compounding, orders are transmitted electronically, and pump results are recorded in the IVWM system.
In this webinar, Andy Teel, Pharmacy Systems Analyst at University of New Mexico Hospitals (UNMH) and Robert (RC) Hellinga, Pediatric Clinical Lead Pharmacist at UNMH, will discuss the advantages of building and implementing an IV workflow system to increase the safety of PN administration.
The value of clearly established SOPs that are consistently reflected in the department’s actual practices cannot be overstated. In this webinar, Patti Kienle, director of accreditation and medication safety at Cardinal Health, will review strategies, resources, and steps to avoid common mistakes with SOPs, with an eye toward USP compliance.
Staying current with USP regulations is an essential pharmacy responsibility. In this webinar, based on PP&P’s State of Pharmacy Compounding survey data for 2022, Fred Massoomi and Deanne Halvorsen will review changing regulatory requirements, recent inspection focal points, and the current state of compliance to USP <797> by hospitals nationwide.
A successful IV workflow system implementation for parenteral compounding requires the incorporation of several key factors including:
USP <800> requires the use of CSTDs for drug administration and recommends the use of CSTDs where possible for drug preparation. While most pharmacies have implemented CSTDs in the pharmacy, usage on the units is not as consistent, leaving facilities at risk for regulatory actions. In this webinar, Fred Massoomi and Seth Eisenberg will review opportunities to ensure appropriate CSTD adoptions throughout the facility.
Identifying and interpreting enforcement trends inside the regulatory actions for 503B outsourced compounders can assist health care facilities in choosing appropriate 503B partners. Furthermore, an understanding of the FDA’s current focus can help hospital and health system pharmacies monitor their outsourcing partners while improving their own compounding programs. Utilizing the largest independent database of FDA compounding activities and documents outside of the FDA itself, Lou Diorio, RPh, FAPhA, of LDT Health Solutions will analyze the long-term trends and current developments in FDA inspections of 503B compounders.